RecruitingNCT07048574

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age


Sponsor

State University of New York at Buffalo

Enrollment

600 participants

Start Date

Jun 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).


Eligibility

Min Age: 18 MonthsMax Age: 11 Years

Inclusion Criteria4

  • Child with a diagnosis of Cystic fibrosis (CF) actively followed by the CF care team at a participating site
  • Child is age 18 months thru 11 years
  • English and/or Spanish speaking
  • Parent/legal guardian willing and able to give informed consent, and for minor participants ages 7 thru 11 years able to give assent.

Exclusion Criteria1

  • Unable or unwilling to participate in study procedures, or at Site PI discretion.

Locations(13)

Children's Hospital of Orange County

Orange, California, United States

Children's Hospital Colorado

Aurora, Colorado, United States

Joe DiMaggio

Hollywood, Florida, United States

Nemours Foundation

Orlando, Florida, United States

Indiana University

Bloomington, Indiana, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

University at Buffalo

Buffalo, New York, United States

University of North Carolina School of Medicine

Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Brown University Health

Providence, Rhode Island, United States

UT Southwestern

Plano, Texas, United States

Children's Hospital of Richmond at Virginia Commonwealth University

Richmond, Virginia, United States

Seattle Children's Hospital

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07048574


Related Trials